MILANO VINCENT (CIK 1187159) reported 9 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-08). Recent activity: Buy ACRS (11,580 shares), Buy BCRX (1,122 shares), Buy BCRX (848 shares), Buy BCRX (783 shares), Buy BCRX (676 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-08 | Aclaris Therapeutics, Inc. (ACRS) | Director | Buy | 11,580 | $0 |
| 2026-06-02 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Director | Buy | 1,122 | $9,997 |
| 2026-03-03 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Director | Buy | 848 | $7,420 |
| 2025-12-02 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Director | Buy | 783 | $5,622 |
| 2025-09-03 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Director | Buy | 676 | $5,618 |
| 2025-06-16 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Director | Buy | 12,500 | $0 |
| 2025-06-09 | Aclaris Therapeutics, Inc. (ACRS) | Director | Buy | 4,793 | $0 |
| 2025-06-03 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Director | Buy | 523 | $5,622 |
| 2025-03-04 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Director | Buy | 653 | $5,622 |
Source: SEC Form 4 filings · as of 2026-06-08